SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) August 1, 2005
Inverness Medical Innovations, Inc.
(Exact Name of Registrant as Specified in Its Charter)
|
Delaware |
|
001-16789 |
|
04-3565120 |
|
(State or other jurisdiction of |
|
(Commission file number) |
|
(IRS Employer Identification No.) |
|
|
|
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 |
|
(Address of principal executive offices) |
|
|
|
Registrant’s telephone number, including area code: (781) 647-3900 |
|
|
|
Not Applicable |
|
(Former name or former address, if changed since last report) |
ITEM 8.01. OTHER EVENTS
On August 1, 2005, Inverness Medical Innovations, Inc. (the “Company”) announced that it had entered into definitive agreements with funds affiliated with 3 accredited institutional investors to sell 4,000,000 shares of its common stock in a private placement at $23.76 per share (the “Private Placement”). The Company’s press release announcing the Private Placement is attached hereto and incorporated herein by reference.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
c) Exhibits. The following exhibit is filed with this document.
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated January 22, 2004, entitled “Inverness Medical Innovations Agrees to Sell 4,000,000 Shares of Common Stock” |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INVERNESS MEDICAL INNOVATIONS, INC. |
|
|
|
|
|
By: |
/s/ Jay McNamara |
|
|
Jay McNamara Associate General Counsel |
Dated: August 1, 2005
3
EXHIBIT INDEX
|
|
Description |
|
|
|
|
|
|
99.1 |
|
Press Release dated January 22, 2004, entitled “Inverness Medical Innovations Agrees to Sell 4,000,000 Shares of Common Stock” |
4